SIGACHI 2025-07-01 2025-09-30 SIGACHI 2025-09-30 SIGACHI 2025-03-31 SIGACHI 2025-04-01 2025-09-30 SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses1Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses2Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses3Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses4Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses5Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses6Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses7Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses8Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses9Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:OtherExpenses10Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses1Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses2Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses3Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses4Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses5Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses6Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses7Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses8Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses9Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:OtherExpenses10Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-04-01 2025-09-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-09-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-09-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-09-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-07-01 2025-09-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-09-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-07-01 2025-09-30 ItemsThatWillNotBeReclassifiedToProfitAndLoss1 SIGACHI 2025-04-01 2025-09-30 ItemsThatWillNotBeReclassifiedToProfitAndLoss1 SIGACHI 2025-07-01 2025-09-30 RelatedPartyTransactionDomain1 SIGACHI 2025-06-30 RelatedPartyTransactionDomain1 SIGACHI 2025-09-30 RelatedPartyTransactionDomain1 SIGACHI 2025-07-01 2025-09-30 RelatedPartyTransactionDomain2 SIGACHI 2025-06-30 RelatedPartyTransactionDomain2 SIGACHI 2025-09-30 RelatedPartyTransactionDomain2 SIGACHI 2025-07-01 2025-09-30 RelatedPartyTransactionDomain3 SIGACHI 2025-06-30 RelatedPartyTransactionDomain3 SIGACHI 2025-09-30 RelatedPartyTransactionDomain3 SIGACHI 2025-07-01 2025-09-30 AuditorDomain1 iso4217:INR iso4217:INR xbrli:shares 000000 NOTLISTED SIGACHI INE368H01018 SIGACHI LABORATORIES LIMITED Main Board Equity 2025-04-01 2026-03-31 2025-11-13 2025-11-04 INR Lakhs Quarterly Second quarter Multi segment 2025-11-13 04:00:00 2025-11-13 18:00:00 true Cash Flow Indirect Declaration of unmodified opinion true true NA NA false true 2025-05-29 www.slllab.com false false NOT TAKEN ANY LOANS AND DEPOSITS 2025-07-01 2025-09-30 Unaudited Standalone 3040000 1460000 4500000 0 0 0 1194000 0 578000 299000 2071000 2429000 0 2429000 1232000 -615000 617000 0 1812000 0 0 0 0 1812000 -2375000 -563000 67531000 10 0.27 0.27 0 0 0.27 0.27 1.The above unaudited Financial results as reviewed and recommended by the Audit Committee are considered and approved by the Board of Directors at their respective meetings held on 13th November, 2025. <BR> <BR> 2.These financial results of the company have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. <BR> <BR> 3.These Financial results have been subjected to limited review by the Statutory Auditors'. <BR> <BR> 4.These Financial Results are available on the Stock Exchange website (www.msei.in) and also on the company’s website at (www.slllab.com). 2025-04-01 2025-09-30 Unaudited Standalone 15816000 3631000 19447000 0 0 0 2245000 0 1156000 686000 4087000 15360000 0 15360000 2293000 355000 2648000 0 12712000 0 0 0 0 12712000 15293000 28005000 67531000 10 1.88 1.88 0 0 1.88 1.88 INSURANCE 69000 RENT 50000 CONVEYANCE EXPENSES 38000 MISCELLANEOUS EXPENSES 15000 LISTING FEE 0 PRINTING AND STATIONERY 47000 OFFICE MAINTENANCE 26000 CUSTODY FEE 0 FACTORY MAINTENANCE 18000 OTHER EXPENSES 36000 INSURANCE 106000 RENT 92000 CONVEYANCE EXPENSES 89000 MISCELLANEOUS EXPENSES 78000 LISTING FEE 55000 PRINTING AND STATIONERY 51000 OFFICE MAINTENANCE 50000 CUSTODY FEE 45000 FACTORY MAINTENANCE 36000 OTHER EXPENSES 84000 50087000 0 0 0 0 0 0 0 329299000 0 0 4362000 333661000 0 21550000 405298000 0 1038000 5526000 8808000 0 0 18656000 34028000 0 837000 34865000 0 0 440163000 73106000 348171000 421277000 421277000 0 0 0 0 0 803000 13729000 0 3500000 18032000 0 0 0 0 689000 689000 0 165000 854000 18886000 440163000 Bulk Drugs and Intermediates (Lease Rents) 3900000 Investments 600000 Bulk Drugs and Intermediates (Lease Rents) 6400000 Investments 13047000 4500000 19447000 0 0 4500000 19447000 Bulk Drugs and Intermediates (Lease Rents) 3304000 Investments 600000 Bulk Drugs and Intermediates (Lease Rents) 5172000 Investments 13047000 3904000 18219000 0 0 1475000 2859000 2429000 15360000 Bulk Drugs and Intermediates (Lease Rents) 92208000 Investments 347955000 440163000 0 440163000 Bulk Drugs and Intermediates (Lease Rents) 18886000 Investments 0 18886000 0 18886000 0 0 -5248000 0 -808000 18075000 0 -1256000 0 0 0 0 1000000 1156000 0 110000 0 -215000 0 0 2138000 4461000 0 -6448000 0 0 0 0 0 -233000 15127000 0 0 0 2293000 0 12834000 0 0 0 2951000 0 0 0 0 0 20216000 2000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2138000 4461000 0 -6108000 -22674000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -9840000 0 -9840000 18648000 8808000 ITEMS THAT WILL NOTBE RECLASSIFIED TO PROFIT OR (LOSS) -3548000 -3548000 ITEMS THAT WILL NOTBE RECLASSIFIED TO PROFIT OR (LOSS) 17068000 17068000 -1173000 1775000 0 0 -2375000 15293000 SIGACHI LABORATORIES LIMITED TUNUGUNTLA RAJASEKHAR EXECUTIVE DIRECTOR Remuneration 986000 APPROVED 986000 2025-05-29 986000 0 0 SIGACHI LABORATORIES LIMITED S LEKHA SAI COMPANY SECRETARY AND COMPLIANCE OFFICER Remuneration 300000 APPROVED 300000 2025-05-29 300000 0 0 SIGACHI LABORATORIES LIMITED BOINA KUMAR CHIEF FINANCIAL OFFICER Remuneration 179000 APPROVED 179000 2025-05-29 179000 0 0 1465000 Unaudited true NSVR AND ASSOCIATES LLP true 2026-06-30